MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2020

    On-Demand Treatment Preferences of Patients with Parkinson’s Disease and “OFF” Episodes: Heterogeneity Across Patient Subgroups

    A. Thach, J. Coulter, C. Leach, J. Sutphin, C. Mansfield (Marlborough, MA, USA)

    Objective: To quantify preference heterogeneity for on-demand treatments among patients with Parkinson’s disease (PD) and “OFF” episodes. Background: Patients with PD commonly experience “OFF” episodes.…
  • MDS Virtual Congress 2020

    Correlation between location of active contacts and weight gain after subthalamic nucleus deep brain stimulation in Parkinson’s disease

    K. Eguchi, I. Yabe, S. Shirai, M. Matsushima, T. Kano, K. Yamazaki, S. Hamauchi, T. Sasamori, K. Hirata, T. Seki, M. Kitagawa, M. Otsuki, T. Shiga, K. Hokin, H. Sasaki (Sapporo, Japan)

    Objective: Objective: The aim of this study was to evaluate the correlation between the location of active contacts and weight gain after subthalamic nucleus deep…
  • MDS Virtual Congress 2020

    All-cause mortality in pimavanserin and atypical antipsychotic users with Parkinson’s disease in Medicare

    A. Mosholder, Y. Ma, S. Akhtar, G. Podskalny, Y. Wei, J. Liao, Y. Feng, H. Lyu, M. Wernecke, K. Leishear, L. Nelson, T. MaCurdy, J. Kelman, D. Graham (Silver Spring, MD, USA)

    Objective: To assess all-cause mortality in Medicare beneficiaries with Parkinson’s disease (PD)  receiving pimavanserin or atypical antipsychotics (AAs). Background: In PD patients, the lifetime prevalence…
  • MDS Virtual Congress 2020

    Towards a scoring system to distinguish early parkinsonian variant of multiple system atrophy from Parkinson’s disease

    P. Millar Vernetti, J.A Palma, L. Norcliffe-Kaufmann, M. Pérez, A. Fanciulli, F. Krismer, W. Singer, P. Low, M.T Pellecchia, H.J Kim, C. Shibao, A. Peltier, I. Biaggioni, M.J Martí, C. Terroba-Chambi, M. Merello, D. Goldstein, R. Freeman, C. Gibbons, S. Vernino, G. Wenning, H. Kaufmann (New York, NY, USA)

    Objective: To develop a clinical score to distinguish between the parkinsonian variant of multiple system atrophy (MSA-P) and Parkinson’s disease (PD). Background: The differential diagnosis…
  • MDS Virtual Congress 2020

    Vascular parkinsonism and Parkinson’s disease: Differences concerning performance in activities of daily living

    R. Jesus, R. Raimundo, A. Marques, C. Azoia, M. Mendes, A. Velon (Vila Real, Portugal)

    Objective: Determine and compare performance in activities of daily living between vascular parkinsonism (VP) and Parkinson’s disease (PD) patients in a hospital-based sample. Background: Despite…
  • MDS Virtual Congress 2020

    Demonstrating the clinical value of MANAGE-PD tool in assessing symptom control of Parkinson’s disease patients: Evidence from G7 countries

    A. Antonini, P. Odin, A. Alobaidi, F. Cubillos, P. Schmidt, Y. Jalundhwala, K. Onuk, J. Zamudio, P. Kukreja, E. Jones, J. Wright, H. Fernandez (North Chicago, IL, USA)

    Objective: Evaluate the clinical value of using MANAGE-PD tool for assessing PD symptom control in real-world setting. Background: MANAGE-PD is a validated [1], web-based tool…
  • MDS Virtual Congress 2020

    Cognitive and psychiatric symptoms are associated with walking difficulties in mild Parkinson’s disease

    B. Lindholm, C.H Brogårdh, P. Hagell, C.H Nilsson (Lund, Sweden)

    Objective: To investigate the association of different aspects of cognitive impairment, depression and anxiety with walking difficulties in daily life in persons with mild PD.…
  • MDS Virtual Congress 2020

    Comparative analysis of the quality of life between healthy elderly people and those with Parkinson’s disease

    L. Santos, A. Alonso, N. Luna, J. Greve (São Paulo, Brazil)

    Objective: To compare the impact of PD on the quality of life and functioning of the elderly with and without PD. Background: Parkinson's disease (PD)…
  • MDS Virtual Congress 2020

    Longitudinal change in dopamine transporter availability in idiopathic REM sleep behavior disorder

    J.H Shin, J.Y Lee, Y.K Kim, H.W Nam, S.A Shin, H.J Kim, B. Jeon (Seoul, Republic of Korea)

    Objective: To elucidate longitudinal changes in the dopamine transporter (DAT) availability in idiopathic rapid-eye-movement sleep behavior disorder (iRBD) patients predicted by the baseline motor and…
  • MDS Virtual Congress 2020

    Asleep versus Awake DBS: Real World Evidence from the Product Surveillance Registry

    M. Schiess, S. Falowski, P. Konrad, G. Plotkin, J.P Azulay, S. Navarro, A. Lopez Rios, K. Stromberg, K. Bhatia, T. Weaver (Houston, TX, USA)

    Objective: Deep brain stimulation (DBS) has traditionally been performed “awake” under local anesthesia using intra-operative test stimulation to confirm lead placement. Several recent studies have…
  • « Previous Page
  • 1
  • …
  • 77
  • 78
  • 79
  • 80
  • 81
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley